Rosai–Dorfman Disease between Proliferation and Neoplasia

Keyphrases

• Neoplasia 100%
• Histiocytes 100%
• Histiocytosis 66%
• Germline mutation 66%
• Syndrome Type 33%
• Clinical Manifestations 33%
• Gene mutation 33%
• Myeloproliferative Neoplasms 33%
• Disease-associated 33%
• Morphological Characteristics 33%
• Self-limiting 33%
• S100 33%
• FAS Gene 33%
• ERK Pathway 33%
• BRAF mutation 33%
• Conventional Therapy 33%
• Sporadic Form 33%
• Histiocytic 33%
• Neoplastic Processes 33%
• OCT2 33%
• CD68 33%
• ERK MAPK 33%
• Local Therapy 33%
• Fascin 33%
• Emperipolesis 33%
• Immune Disease 33%
• B Symptoms 33%
• CD163 33%
• Extranodal 33%
• Cervical Lymphadenopathy 33%
• Family Forms 33%
• Faisalabad 33%
• Extranodal Involvement 33%
• MAP2K1 33%
• Autoimmune Lymphoproliferative Syndrome 33%
• H Syndrome 33%
• SLC29A3 33%

Medicine and Dentistry

• Disease 100%
• Neoplasm 100%
• Histiocyte 27%
• Germline Mutation 18%
• Histiocytosis 18%
• Morphology 9%
• Immunopathology 9%
• Gene Mutation 9%
• Cervical Lymphadenopathy 9%
• Oncogenesis and Malignant Transformation 9%
• Emperipolesis 9%
• Local Therapy 9%
• B Symptoms 9%
• Myeloproliferative Disorder 9%
• Fascin 9%
• Mitogen-Activated Protein Kinase 9%
• Chlordane 9%
• Autoimmune Lymphoproliferative Syndrome 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Neoplasm 100%
• Histiocytosis 18%
• Chlordane 9%
• Syndrome 9%
• Myeloproliferative Disorder 9%
• Immunopathology 9%
• Oncogenesis and Malignant Transformation 9%
• Fascin 9%
• Cervical Lymphadenopathy 9%
• Autoimmune Lymphoproliferative Syndrome 9%